Cybin Irl Limited
Clinical trials sponsored by Cybin Irl Limited, explained in plain language.
-
Breakthrough depression therapy enters final Long-Term testing phase
Disease control ENROLLING_BY_INVITATIONThis study follows up on earlier trials to see how safe and effective the investigational treatment CYB003 is over the long term for people with major depressive disorder. It includes 468 participants who have already completed one of two previous CYB003 studies. The main goal is…
Phase: PHASE3 • Sponsor: Cybin IRL Limited • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New anxiety treatment enters Mid-Stage testing
Symptom relief OngoingThis study is testing an investigational medicine called CYB004 in adults with moderate to severe generalized anxiety disorder (GAD). It aims to see if CYB004 can safely reduce anxiety symptoms in people whose current medications aren't working well enough. The trial will compare…
Phase: PHASE2 • Sponsor: Cybin IRL Limited • Aim: Symptom relief
Last updated Mar 27, 2026 12:39 UTC